Submitted by Keysight Technologies
Keysight has released Vital Signs, a new survey that reveals that the healthcare industry lags other industries in deploying test automation practices to ensure the quality of the software that physicians use to provide patient care.
The survey found that 82% of U.S.-based healthcare executives, decision influencers, and IT professionals polled in collaboration with the Healthcare Information and Management Systems Society (HIMSS) said their organization relied on manual or do-it-yourself (DIY) software testing methods.
"The healthcare industry's current software testing practices remain deeply tied to workflows born of a paper-based world that favored manual and homegrown solutions," said Gareth Smith, General Manager of Software Test Automation at Keysight. "Having this legacy mentality comes with real costs, whether it's maintaining a complicated custom-built testing solution or having QA teams burdened with repetitive manual testing tasks."
With 38% of respondents relying on manual testing and 44% on DIY testing approaches, there is an opportunity for the healthcare industry to improve overall software quality for physicians, nurses, and support staff through automation. This is reflected in the longer-term software testing goals of respondents, with 75% stating they plan to move to primarily automated testing during the next five years.
Other key findings from Vital Signs, include:
"The results of our joint survey with Keysight highlight gaps in software testing across healthcare providers," said Nicole Ramage, Sr. Market Insights Manager, HIMSS. "It is clear that the industry understands the value of implementing automation technologies to ensure software quality, which in turn can improve patient care."
To help IT professionals in the healthcare industry address these challenges, Keysight offers an AI-powered suite of software test automation solutions tailored to healthcare. This includes non-invasive EMR testing at DevOps speeds, end-to-end medical device software testing, and HIPAA-compliant testing solutions.
"We see that the industry is poised to take advantage of modern test automation tools," said Smith. "Powered by AI, Keysight can automate the entire EMR testing process to effectively address any gaps in providers' current testing practices. This can enable QA teams to perform their existing tests more consistently across platforms and test more extensively than with manual or DIY approaches."
At Keysight (NYSE: KEYS), we inspire and empower innovators to bring world-changing technologies to life. As an S&P 500 company, we’re delivering market-leading design, emulation, and test solutions to help engineers develop and deploy faster, with less risk, throughout the entire product lifecycle. We’re a global innovation partner enabling customers in communications, industrial automation, aerospace and defense, automotive, semiconductor, and general electronics markets to accelerate innovation to connect and secure the world. Learn more at Keysight Newsroom and www.keysight.com.
More from Keysight Technologies